On the Future Advances in Engineering and In-Vitro Culture of Human Embryos by Anton, Roman
MPRA
Munich Personal RePEc Archive
On the Future Advances in Engineering





MPRA Paper No. 71450, posted 20 May 2016 09:03 UTC
 1 
2016 | Vol. 3 | Issue 1 | IDEAS 
On the Future Advances in 
Engineering and In-Vitro 
Culture of Human Embryos  
Roman Anton*  
Recently, two embryologist laboratories have 
independently and jointly reported that they 
have teamed up and successfully cultured 
human embryos in-vitro beyond the previous 
technical obstacle, as well as the widely and 
also generally accepted moral and legal limit, 
of the implantation stage1,2: i.e. DPF day 14 
(days post fertilization). Although this new 
model system can offer many interesting 
new insights into human development, it also 
represents an ethically highly complex and 
controversial issue. Another big break with 
recent ethical taboos and widely accepted 
standards, and hence R&D constraints, has 
also occurred recently, as Chinese scientists 
for the first time genetically manipulated 
human 3PN [tripronuclear] zygotes [which 
are the ‘remaining’ lower quality zygotes, 
while 2PN zygotes are used for human IVF, 
in-vitro fertilization], and also the resulting 
embryos, using a relatively new and powerful 
genome editing CRISPR/Cas9 technology, 
which is yet still in its very biomedical and 
methodological infancy (nevertheless, this 
method is already used manifold, likely due 
to a “keyword derived grant success effect”). 
Both, in-vitro culture and human engineering 
have very far-reaching implications: Already 
today, it is of highest particular importance to 
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mention that the way is about to be paved for 
new in-vitro “embryogenic engineering 
strategies” emerging in the future, which will 
plan to also make use of human embryo in-
vitro culture methods (for method prediction 
see Fig. 1) instead of the pretense to only try 
to get clues for rational design of better stem 
cell differentiation protocols. Rational design 
can be predicted today to not find all major 
clues due to inherent embryonic complexity. 
The use of an ECM matrix is only a natural  
exception, as it doesn’t correspond to the 
highly regulative auto-patterned embryonic 
development - but enables it here from the 
outside. Hence, one can already predict 
today that “embryo cultures” will be used as 
additional stem cell differentiation protocol in 
the future to yield all cell types of the body, 
rsPSCs3, and even various precious adult 
stem cell precursors, and embryonic organs4 
- that could be subsequently grown in-vitro, 
or in-vivo xenografts (in this case organ 
growth). This discussion shall review and 
add some crucial new points to this debate.  
 
Fig. 1 Prediction of potentially emerging embryogenic 
in-vitro methods that would also require an extension 
of the Carnegie 6a limit, causing unseen ethical issues. 
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Carnegie 6a: The Day-14th Rule 
So then, human embryos were cultured in-
vitro beyond the implantation stage using a 
simple growth media and a widely used and 
simple implantation matrix, which bears a 
standard complex mix of ECM proteins1,2,5 
(matrigel) to substitute for basal membrane 
signaling. This new procedure thereby allows 
a natural self-organizing autonomous growth 
of the hereby attached embryos, or also 
pluripotent stem cells, likely enabled by a 
critical cell mass, a blastocyst cave structure, 
geometrically, cellular polarity/structure and 
via signaling, e.g. of the basal membrane 
with integrins (β1)5: a cell to matrix signal, 
anchor and mobility, and informative 
interaction hub. Moreover, at this point, the 
advanced in-vitro protocols of the two new 
publications also indicate that these culture 
methods seem to already allow today - or 
very soon - yielding even much higher 
human embryonic stages in-vitro. In fact, the 
fallen technical hurdle puts all “too-curious” 
scientists on “a collision course” - but also 
makes any future control of it much more 
difficult. In between the lines, the studies 
indicate the potential of a technical feasibility 
far beyond day-14 that may be astounding 
but is not allowed by many and relevant 
national laws6 and international guidelines of 
today6, and this prospect is also prohibited to 
be tested in experiments (so how can we 
finally know and not guess?). Nevertheless, 
the in-vitro culture potential has already 
become another key reality and 
technological point of argumentation in the 
global debate about a potential shift of the 
allowed embryonic time limit. Initially, the 14-
day DPF day-14 time limit was implemented 
internationally by 12 countries as three of the 
authors have also briefly reviewed here6. But 
already today, they conclude and strive for 
revisiting and extending the international “14-
day rule” - but why so fast and so early, one 
might wonder? Where does the necessity 
arise for a fast change, from “competition”? 
A motivational driver usually is the scientific 
kudos. Hence, it is very likely that functioning 
protocols already exist and the hidden R&D 
potential behind these new embryo culture 
strategies promises more of it - if they were 
allowed ethically and legally (the R&D limit 
seems to be already the day-14 limit). In fact, 
already today, the day-14 rule is not taken as 
serious by scientists, as the legislator could 
have originally meant or intended it, 
potentially indicating some standard erosion. 
However, it really makes in fact very much 
sense to technically look at the 
developmental stage6 and not the day post 
fertilization (DPF). Hence, it would be at 
least technically better (without giving a 
moral connotation) to define a specific 
developmental stage and not a specific DPF, 
also due to the different timing that can occur 
in-vitro, which was also found before in the 
“in-vitro differentiation speed” of embryoid 
bodies derived from embryonic stem cells 
(ESCs)7. Since it is not possible to arrest 
development at this stage, instead of the 14-
day DPF stage, it were better to use the 
developmental stage defined term “Carnegie 
Stage 6a” that corresponds to the primitive 
streak, body plan, and the axis formation 
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stage, as well as individuation, and distinct 
pattern formation, while a spatio-
temporalization takes place alongside with a 
process called germ layer pre-specification, 
including differentiation into the neuro-
ectoderm making the prospective brain/CNS. 
Hence, the distinctly defined sub-stage term 
”Carnegie 6a” not only makes very much 
sense from a legal-political, but also from an 
embryologic and scientific point of view. 
 
Additional Points for the Ethical Debate 
The “day 14 guideline”, which was, however, 
implemented in the real-world laboratories as 
“Carnegie 6a” and in the studies, should be 
thus legally adjusted, like the international 
guidelines to “Carnegie 6a”, even if such 
would be further extended one day for a 
specific but highly controlled purpose. The 
Carnegie 6a or day 14 DPF line was also 
intentionally drawn6 close to the point when 
the very early neural progenitor cells of the 
prospective CNS/PNS first develop in the 
neuroectoderm (a precursor blastodermic 
layer of the embryo). The basic logic behind 
most of our ethical decisions stems from a 
widely unexpressed belief and assumption 
that the “functioning nervous system” and 
“cognitive self” would entitle us to “human 
rights” - and, as it also seems, not one of the 
other cell types of our body (a neurocentric 
ethical and senior anthropocentric minted 
logic). Hence, today, our non-neural body 
belongs, somehow, like a biological property, 
to our respective and functioning CNS/brain, 
and is used and owned by it every moment, 
also in most relevant legal contexts. But, it 
cannot exist independently without our body 
and has achieved to bear the human rights 
comprising the legal rights that its biological 
assets of the individual remain undamaged 
and “free”. This dominating argument of 
partial cognitive neuroscience originally 
stems from the idea that our perception, 
feeling, consciousness, thinking, and so on, 
is a key prerequisite for our self and being, 
and thus of our human rights that are more 
legally-bureaucratically termed “moral status” 
these days and also in this debate. This is, 
for example, why our medical systems may 
treat a diagnosed “brain-dead patient” as 
“clinically dead” (moral status of a dead), 
which self-allows the medical practitioner to 
even stop all life-support, like machines, 
even if only cognition is somehow deeply 
impaired (with some exceptions still given).  
 
“Can you really give a human embryo the 
moral status of a dead human person?” 
 
The answer is no and indicates that the 
entire idea behind giving a “moral status” is 
misleading due to the multidimensionality of 
the dilemma. But this also doesn’t mean that 
a final conclusion is reached here - also due 
to the multidimensionality of the same 
dilemma. Additionally, that “no final 
conclusion is reached” doesn’t mean that 
this is a final conclusion that is reached 
about this topic in any way and that a line 
can or cannot, or should or should be not 
drawn somewhere in the sand. However, it 
can be concluded that all dimensions and 
facts and all contexts have to be considered 
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in a well-weighted and unbiased but at the 
same time also political manner - which is in 
fact also a dilemma - and that the answer 
can be still either yes, no, or in between, i.e. 
in the sand. Thus, this is actually where the 
discussion should start and not where it 
ends. From the previous example, we may 
derive that the functioning of the human 
brain/CNS is also in our health care system 
the underlying defining feature for the steady 
admission of “human rights” and the “human 
right to live”. Whenever it comes to such 
definitions, we can find that the overall 
functioning of the CNS can be in fact defined 
“quite differently”. Functioning is more 
ambiguous than often and widely 
anticipated. Hence, until today very many 
inconsistencies in this CNS-derived logic, 
justification, jurisdiction, and ethical rationale 
of human rights still exist, as “functioning” 
can be defined and technically assessed in 
many different ways, also in the “human 
embryo ethics standards and stage limit 
debate”. What might seem to some of us 
maybe like somewhat “scientifically irrelevant 
philosophic thinking”, nevertheless, finally 
drives all of our hard-fact decisions, laws and 
also standards about this methods and thus 
also science. For instance, also the basis of 
the “moral status” that we admit to 
embryonic life and other life, for instance, a 
“potential extra-terrestrial life” or to animals 
of this planet. The mentioned inconsistencies 
also persist here, and once again due to the 
ambiguous definition of “functioning”. To also 
give some example for this ambiguity: (1) 
what if we are not very intelligent relative to 
extraterrestrial life [would our brains maybe 
start to claim our right to live differently?], or 
a real-world down to earth example (2) about 
65 billion animals with very high cognition, 
with intelligence, and also a very complex 
CNS are still mass slaughtered per year, as 
their CNS does not seem to entitle them to 
specific or equivalent rights” - according to 
our CNS that defines functioning via a higher 
and more anthropocentric type of quality in 
cognition. “Quality of cognition and thinking” 
is likely to be much biased since it is always 
defined by a thinking that entitles itself (there 
is not “one measure or way” to test it). A 
more specific comparison in this context 
might be the nationally highly related and 
often debated legal time limit on human 
abortion. Many countries orient on the 
Carnegie 6a stage, i.e. the 14-day rule, but 
“much later legal limits” are also found with 
up to 90 days, for example in Italy, or even 
up to “full viability reached by the biologically 
independent child”, e.g. in the Netherlands, 
which can be up to ca. 160 days, or week 
22. This very late stage corresponds with an 
already very much developed human 
embryo, brain, and individuality. One could 
also easily argue that an already “functioning 
brain” can be diagnosed depending on how it 
is de facto tested and assessed (ambiguity 
and qualms increase with stage). That week 
22 might be in fact a limit set too late, is also 
seen by many professionals from the 
medical field, and the fetus and brain may 
even feel pain already before week 208 
There are in fact reasons to speculate that a 
“preliminarily functioning” brain is very likely 
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to be found yet in much earlier stages. 
These facts and ambiguities should be better 
researched (if this is ethically and technically 
possible) and they still need to be better 
understood. That “a line is drawn in the 
sand” - as it was stated by the three authors6 
- is correct, but it cannot be used as an 
argument per se to shift this line in one or 
the other direction. “Arguments can be 
found” to draw the line at very many stages 
starting from stage 0 - as a human life frame 
has an ethical value that can be in fact 
weighted differently. By trend, some religious 
people might weight it 100%, less-religious 
scientific people might see it close to 0%, as 
only some cells that do not think or feel, and 
there would be also a very high somatic cell 
turnover every day; but these somatic cells 
would not team up to generate a new human 
life (generation of IPSCs9 are an artificial 
exception to this rule that only happens in 
the laboratory). Still, this situation indicates 
the existence of multiple relevant dimensions 
and that a more complex ethical issue is 
given here, which needs to find a way to 
integrate all scientific, technological, societal, 
social, ethical, religious, medical, cultural, 
criminal, philosophical, and human rights 
questions, and all of the related or respective 
contexts, by carefully and exactly weighing in 
all of the manifold contemporary and future 
associated risks and opportunities, and how 
they would really turn out to transmit de facto 
in the realm of possibility of the real world. 
Additionally, today’s “attainable feasibility of 
controlling” of such embryogenic procedures 
to avoid potentially undetectable breakings 
of the law should be also better considered. 
Future long-term strategic implications and 
“nash equilibria” should be also kept in mind. 
 
Advances in Manipulation of Human Life  
For the first time in history, human embryos 
are genetical modified, somatically and also 
(very likely) in their prospective germline10. 
Also, many additional genetic, epigenetic, 
cytosolic, and other molecular modifications 
are already thinkable today. February this 
year (2016), the UK’s HFEA† allowed - also 
for the first time in history - to genetically 
engineer human embryos in a so-called 
western country, which is facilitated by 
further advancing genome editing methods 
like CRISPR/Cas911–13. As a result, human 
embryos are already routinely modified and 
engineered using the “remaining 3PN 
zygotes” from IVF procedures. This first 
report about this strategy published by 
Chinese scientists in 2015 demonstrates the 
feasibility to genetically manipulate human 
zygotes and embryos10,14. Noteworthy, these 
scientists were still facing several significant 
difficulties with the method and indicated that 
the “fidelity and specificity” of their protocols 
must be still further improved a lot for all 
potential clinical applications (low efficiency, 
high-risk off-target effects, mosaic editing)10.  
 
Mosaic Editing, Allele Complexity & More 
The notion of the Chinese report of mosaic 
editing, post-human zygote manipulation,  
reveals how we can estimate the state of the 
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recent methodological affairs10: The CRISPR 
/Cas9 method is still very much in its testing 
phase. The mosaic phenotype is also known 
from inducible homologous recombination in 
ESCs and embryos (not shown) or CRISPR 
methods in other mammalian systems15, i.e. 
mouse embryonic stem cells and the early 
embryos. By only looking at the particular 
methodological and genetic risks it becomes 
already fully apparent that human genetic 
engineering is not justifiable today and there 
is still a long way to go while adverse genetic 
effects are better researched in mice. The 
genetic manipulation of the human germline 
bears too many uncontrollably high risks.      
 
Embryology-driven ESCs Methods  
It has become clear that the most powerful 
embryonic stem cell protocols are likely to go 
“the specific route of embryology” - although 
differentiation not always has to take this 
strict path and can also sometimes take 
“alternative, more artificial routes” (e.g. in the 
engineered non-embryogenic cellular ESCs 
in-vitro differentiation protocols). Despite this 
ambiguity, it is still argued today that the only 
and best way of rational design of the  
differentiation protocols for human, mouse, 
and maybe all mammalian stem cells, is to 
“learn from embryology to resemble it in-vitro 
in the stem cell differentiation cultures”. This 
is also a key argument and the last outlook 
given by the recent reports1,2. However, this 
argument might be used to put regulators 
and populations mind at ease - and there is 
an even later and more far-reaching outlook 
to be given, which is actually already much 
thinkable today and “not unrealistic” but even 
“likely to happen in the future”: technically, 
as one could easily agree, the best way to 
resemble something is, in fact, to do it 
exactly the same way. Thus, the best way for 
regenerative medicine stem cell research to 
resemble embryology could be to enable 
embryology itself in-vitro - and the new 
reports indeed show a new and high method 
potential and maybe hidden affinity for such 
embryogenic strategies and approaches1,2. 
To best resemble embryology in vitro, future 
scientists could thus enable or simply (only 
requires IVF plus growth culturing methods - 
differentiation would go its programmed way) 
perform embryology in-vitro, and the reports 
and demands to extend the day 14 Carnegie 
6a limit are probably only the very first step 
in doing so, and many steps alike are about 
to follow. Hence, the kudos-drive will prepare 
the society for sequentially higher staged 
limits of embryo experiments fueled by the 
promise of salvation of new embryogenic 
tissue and organ transplantation medicines. 
Hence, these developments have to be also 
seen in the emerging context of potentially 
arising goals of the emerging future applied 
embryo engineering research. Nevertheless, 
most researchers, even the leading experts 
in the field, still did not fully mention the big 
picture or the future potential and risk of 
these methods, as it can seem, including 
these very latest breakthrough reports1,2 
(05/2016). Already today, aside from IVF, the 
use of blastocysts also provides another 
technically feasible “embryonic vehicle” to 
perform all steps of differentiation within 
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embryologic contexts (Fig.1). Embryonic in-
vitro culture is a promising scientific field on 
the other hand for all sorts of R&D purposes: 
(1) to better understanding in a “model 
system” human (early) embryology and 
development (the model system is not only a 
model it is the subject itself), (2) for rational 
design of cellular in-vitro differentiation 
protocols, but also (3) of human genetic and 
other types of engineering, and (4) of 
embryo in-vitro culture techniques to harvest 
primordial cells and organs4 that could be 
grown in-vitro and as xenografts for 
regenerative medicine, rejuvenation, and 
new organ transplantation. Approach 3&4 
both bears high ethical risks of (I) e.g. 
human embryo culture for scientific 
commercial and additional purpose; or (II) 
potential non-human and human chimera 
biohazards e.g. with ESCs, IPSCs9, 
rsPSCs3; or (III) genetic engineering, (IV) 
germline manipulation, and additional 
thinkable biohazard of human engineering. 
Simplified, with other words and highlighting 
the real implementation risks: in the future, 
one could, for example, start to sell in-vitro 
differentiation products that were secretly 
generated via embryo-methods and hidden 
embryo manipulation techniques and alike. 
Such powerful embryo methods could 
theoretically fully escape public control and 
could comprise engineered and chimeric 
human life forms that can bear the potential 
of genetic ethical and utterly devastating 
human individual and societal disaster. 
Maybe that is also a reason why this was not 
mentioned in the R&D outlook of the recent 
reports1,2, which is only the very beginning of 
such potentially emerging embryogenic 
technologies. But still, these coherences and 
potential risks must be explained to the 
public and policy makers at some point, 
somewhen, and also somewhere: that’s why 
they are claimed here to start a discussion.  
 
“All potential risks must be explained to 
the public and policy maker” 
 
Another potentially high risk of these new 
opportunities also stems from a high level of 
uncontrollability that also arises especially 
from those risks that are not on the regular 
and public map of our understanding. The 
right legal measures should be taken and 
must be found in the future based on a full 
understanding of all possibilities and risk 
potentials, contexts and dimensions, which is 
the initial idea of this discussion here. Now 
that embryos can be cultured in-vitro, a 
longstanding technical hurdle was somehow 
easily taken and more technical hurdles can 
be predicted to potentially fall if a publication 
and procedure is allowed. Today, there is 
already a significant risk and moral issue  
that arises whenever (1) human or humanoid 
embryos are cultured or whenever (2) ESCs 
are differentiated into human and chimeric 
non-human blastocyst-derived embryos (e.g. 
mouse16, swine, monkey, and so on) in order 
to generate “precious primordial stem cells”, 
or “rsPSCs3-like cells”, which by the way also 
work in ethically controvertible inter-species 
pluri- or multipotent stem cell xenografts3, 
tissues, and organs4 in-vitro and in-vivo (see 
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brief summary prediction in Fig.1), and (3) 
genetic manipulations of the germline, etc. 
These risks should be much better controlled 
to prevent a potential misuse today, also in 
light of the feasibility of late stage chimeras 
and the “incentives of organ generation”.  
 
“Human embryo xeno-chimera disasters 
and genetic hazards must be prevented.” 
  
For some readers less familiar with the topic, 
it might seem ‘counterintuitive’ that stem cell 
science could now choose to go embryonic, 
as the authors have just identified new 
culture ways to go in-vitro, and in-vitro 
methods would advance fast - seemingly. 
Nevertheless, they, in fact, only assured a 
new in-vitro way to go embryonic in-vitro to 
undergo it's in-vivo stages in the absence of 
“external” maternal tissues mimicked here1,2.  
 
“The embryonic path could be seen as 
the fast and easy lane of differentiation 
into all body tissues, organs, and cells”.  
 
This embryonic fast-track comes along with 
high potentials: high opportunities and also 
high moral and human risks. The in-vitro 
advances are in fact on the extra-embryonic 
side of in-vitro development: the blastocyst’s 
implantation while the program of self-
organization of the human embryo devoid of 
maternal tissue1,2 is running best in the 
embryo context. Put simple, as mentioned 
also in my thesis, the high level of inevitable 
self-organization is based on an “anticipated 
auto self-patterning mechanisms of ESCs” 
(embryonic stem cells) in the blastocyst, later 
the so-called epiblast cells that form the 
primitive streak embryo that forms a critical 
mass that in turn interacts in the blastocoel 
with the blastocyst’s basal membrane and 
geometric cellular structure. Hence, to fully 
resemble embryogenesis one can start with 
IVF (zygotes; fully feasible) or a blastocyst 
stage (partially feasible engineering; usually 
chimeras; but method potential generally 
given), while it is still thinkable that optimal 
in-vitro protocols could be found to 
circumvent this approach one day, which not 
necessarily has to be “fully reflecting the 
underlying embryology” (i.e. resembling the 
embryonic molecular-genetic sequence of 
cellular states), but can be also found via 
engineering and screening strategies. 
 
“If scientists will one day make use of 
this emerging embryologic differentiation 
method, and if they want to grow e.g. a 
human eye, the embryo that they will 
have to sacrifice for that will also have a 
highly developed human brain and stage, 
causing an unseen bioethical dilemma” 
 
 
Blastocyst Stage “Embryonic Vehicles” 
Today, it is technically still not possible - or 
unthinkable - to rejuvenate embryonic stem 
cells into a zygote or into multicell-embryonic 
stages (Carnegie 0-2, see Fig.1). This would 
allow for in-vitro blastocyst development, a 
powerful embryonic stage vehicle for a full 
embryonic program induction. Additionally, it 
is still also not possible to create a blastocyst 
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in-vitro (ca. Carnegie 2-3), which would be 
another technical producibility breakthrough 
as the blastocyst is still the key vehicle for 
many embryonic stem cell strategies and to 
“go embryologic“ in engineering protocols. 
Yet, also recently, new technically promising 
reports indicate that this could be feasible 
one day17: for instance human ESC-derived 
trophoblastic spheroid implantation models17 
could maybe become a next further 
advancement. Although ESCs could 
technically give rise to trophectoderm (TE) 
cells, so far, a functional blastocyst has not 
yet been engineered from scratch, in early 
2016; but the point is: it could work one day. 
Then, blastocysts filled with ESCs could be 
developed into embryos in-vivo and -vitro. 
So what has in fact happened here to ESC 
biology is that it starts favoring to “also go 
the embryonic route”, which means taking 
real embryos instead of finding tremendously 
complex in-vitro ESCs protocols (e.g. for 
entire organs4), while stem cell progenitors 
seem more feasible to be found in-vitro 
without embryogenic protocols. Knowingly or 
not, as this strategy was not mentioned in all 
the reports, which only conclude to focus on 
the rational design of ESC in-vitro protocols 
while forgetting about the potentially evolving 
embryogenic protocols1,2. The technical 
reason for the embryogenic need in the 
protocols is that the early stages of ESCs, 
especially the ones around the “Carnegie 6” 
stage, all have to go through a spatio-
temporal signaling attached-blastocyst auto-
patterning phase, which is also likely to be 
geometrically and structurally primed, and 
via cell polarity and signaling 5 also with the 
basal membrane e.g. mainly integrin β15. 
The early ESCs stages have to deal with the 
auto pattern formation program that happens 
best in a natural context and the “framework 
of the blastocyst” - and only a partial semi-
auto-patterning can be observed with ESCs 
alone18 in vitro (not a full functional embryo 
formation - only a resembling of embryonic 
patterns). All ESCs and embryoblast self-
organization is, in fact, expectable from their 
described nature and from all what we know 
today about their biology - but it is still a 
legitimate new point that was made in the 
experimental findings that  now clearly seem 
to validate the predominant previous views. 
With other words, “ESCs need to undergo an 
independent bottleneck of priming” and self-
patterning within a spherical or flattened 
spherical/disc like stage: and the best way to 
enable all development lines at once seems 
to be the original embryonic development  -
and the very high early interdependence of 
all tissues could make this a requirement.  
 
Embryologic cell fate interdependence 
makes the “embryogenic protocols” a 
potential future requirement for the 
creation of complex organs and tissues.  
 
For example, during development, one early 
tissue sends important key cues and signals 
to its adjacent tissues of a different cell fate 
tissue, organ, cell type, function, and future. 
This is an important method aspect of future 
R&D that has been seemingly forgotten 
here, like how to deal with the unseen 
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complex ethical issues and dilemmas of 
human embryo generation and (mass) 
destruction, manipulation, and engineering? 
How to prevent human xeno-chimerism and 
human genetic hazards or embryo crimes? 
Can potential future biomedical opportunities 
outweigh all of these high risks? The new 
methods establish a new deep dilemma and 
divide. It is already very clear today that it 
requires new ways to regulate and control 
these biomedical procedures with human 
life: i.e. human early life would have to be 
destroyed to cure another older human life, a 
new biomedical phenomenon of the more 
traditional “passed down senior domination” 
in human societies. Like everywhere, like 
also in science where the senior scientists 
dominate our views and finding and junior 
scientists like me have it difficult to publish 
(due to publication costs only senior faculty 
networking peers) like any of such concerns 
or “future technology predictions” (Fig. 1).  
 
A human science-fiction nightmare 
becomes more reality - but a biomedical 
dream of regenerative medicines too.  
 
Also, patient-specific IPSCs9 grown in-vitro 
could also give rise to patient specific organs 
using spare part clones of themselves and 
alike. Ways will be found to sacrifice the 
remaining embryo “at the earliest Carnegie 
stage possible (approach)” due to the high 
moral issues, while stem cells, organs4, and 
primordial tissues are isolated and could be 
grown elsewhere. Non-neural embryo culture 
(conditional CNS KOs) will be found as an 
optional (but still problematic) alternative (a 
human embryo generated without a brain 
would maybe have a different legal “moral 
status” in the future, but there would be a 
rudimentary brain/CNS leftover, a possibility 
that would cause highest ethical concerns). 
“Tomorrow” this would be maybe nothing 
that the population could fully agree with, 
hence it will be maybe an in the details kept 
biomedical secret that nobody will be able to 
check privately without a permission that 
nobody is granted except some “established 
seniors” (like it is already today in science to 
some extent). It could be also an ongoing 
subject of a “systematic censorship”, and so 
on. Also, animals could be theoretically 
cultured this way one day (CNS-less), and 
then electrically enervated to build up muscle 
- but to escape this dilemma? But what 
would you think, if an “alien species” or a 
“genetic slave driver” would do exactly the 
same with us, or to us? We would most 
probably reject this idea, wouldn’t we? Such 
theoretical questions could probably help to 
reveal a more unbiased understanding. An 
opportunity-risk-dilemma will likely always be 
inherent all of these methods. The more 
valuable the tissues, cells, and organs4 
gained, the later the embryonic stages by 
trend, the higher the ethical dilemma and 
moral issues that will arise not only from its 
misuse but also from its use: hence, 
opportunities will try to outcompete the risks. 
 
Embryo Policy Dilemma  
Contemporarily, it might be alarming to see 
that the two most and widely agreed upon, 
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axiomatic and broadly incontrovertible moral 
standards, taboos, and also legal-political 
regulations about human life, are breaking 
away so easily and quickly, and nobody 
seems to be able to stop this development, 
which now widely becomes a new normality 
and reality. This trend is much in line with the 
globally observable reduction of moral and 
democratic standards, and also in this case 
due to the international technology race and 
a predominant game theoretical thinking 
found worldwide: “The: if we won’t do it, 
someone else will do it thinking”. E.g. due to 
a lack of international standards, which could 
be maybe called a “global UN standard 
deficiency”. To be more specific, only some 
years ago, the human germline was a totally 
agreed upon, and totally untouchable, taboo 
for all scientists in many countries. It is now 
falling so quickly, so unnoticed, seemingly 
like in a salami swindle. What might be good 
for scientific progress bears the societal 
costs of “potentially uncontrollable misuse”. 
China and also the UK will now officially and 
routinely culture and also modify human 
embryos11,14 and an international law still 
remains elusive and seems, like all urged for 
international laws, very infeasible today - 
despite their need. Hence, a reform of the 
UN might be proposed also from this frontier 
to make it more capable of acting. 
  
Let’s think of real world examples: Would 
you allow destroying an early embryonic 
human life - and up to which embryonic 
stage - e.g. to give back sight to a blind? 
 
So far, by now the US and many other 
countries have moved to resist and block 
these trends at least to some significant 
extent of measures19 to embark on the quest 
for finding the best contemporary solution for 
the dilemmas.Additionally, many top expert 
scientists have urged to fully prevent 
germline manipulation20 due to inherent and 
uncontrollable risks, but also to prevent all of 
the hidden and unknown risks. There is still 
too many details and risks that are not fully 
understood10 and once a genetic disaster 
has spread - it could be difficult to stop it. 
 
Thus, any potential genetic poisoning of 
the human gene pool via the germline 
must be prevented systematically. 
 
Experimenting with human life is always a 
very difficult moral issue: e.g. embryo 
manipulation, but also our clinical trials. The 
reader should please notice that all of these 
futuristic new “embryogenic methods and 
human genetic manipulations” are potential 
trends that are not all going to happen in the 
next decades but some could. The point is 
that they can become a bigger reality one 
day, in a more distant future, which will be 
prepared for maybe already today, and some 
methods already today work to some extent. 
Additionally, the moral and ethical questions 
of the problem are also much predicated on 
the adverse societal context and all of the 
risks of this technology - again including the 
point that hidden violations of the law seem 
to become much more feasible over time. 
Also, several potential violations cannot be 
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systematically screened for today: e.g. 
human embryonic stem cells could be 
propagated indefinitely in laboratories, just 
secretly, like HeLa cells, of which scientists 
have generated more than ca. 20 tons until 
today (of HeLa in 2014). So, how to prevent 
a misuse here? Human ESCs (hESCs) could 
be also injected into blastocysts to give rise 
to engineered, modified, chimeric and non-
chimeric embryos even in medium-cost labs 
all around the world. The same holds true for 
the abundance of human zygotes (3PN, 
2PN, 1PN) that could be easily miscounted 
or also accounted differently and transported 
frozen around the globe. This indicates that 
“a lack of controllability already exists today”. 
How should that get any better in the future 
with all of the new methods evolving? 
“Should that happen via an obligatory human 
life surveillance officer in all embryo 
laboratories and clinics, in all countries?” 
That could be probably too expensive. Later 
on, genetic germline modifications and new 
embryo production techniques are also very 
difficult to be found or detected. Although 
these opportunities and risks might be still 
much “like dreams and nightmares of the 
future”, it seems to be obligatory already 
today, to think them through, to prevent fatal 
situations and technological nash equilibria 
from forming before it is too late for a 
prevention strategy. 
 
Future Implications and Moral Issues  
Finally, the added and reviewed points of 
risk are briefly summarized here: (1) the risk 
to human life and the society from human 
embryo culture; (2) the risk of human 
genetic, epigenetic, somatic, germline, and 
other modifications, or otherwise engineered 
human life forms; (3) risk to human life from 
embryonic in-vitro culture; (4) risk of “human 
xeno-chimera embryo biohazards” and life-
forms [genetic, cellular, neuronal, late-stage, 
etc.]; (5) risk of moral hazards stemming 
from embryogenic production, in-vitro human 
spare parts (6) neuronal KO and semi-KO 
and all sorts of neuro-manipulation, genetic 
manipulation of human behavior (7) genetic 
slavery or genetic divide (8) long-term social-
genetic risks: a society that is further 
subdivided into rich and poor could drift in an 
irreversible “genetic discrimination nash 
equilibrium”; (9) risk of genetic manipulation, 
screening, asymmetric information, the 
general risk that the public is not well 
informed by the media and news; this also 
includes censorship, and policies to not 
explain it to the public and media, scientific 
and journalistic self-censorship; and (10) 
other future social structure risks: only a 
society with fair hierarchies and free political 
structures, a fair foundation of human rights, 
fair wealth and information distribution, and 
fair sustainable standards for all, could be 
able to best manage all of the high societal 
scientific and biomedical quality standards, 
R&D and human-genetic and -embryogenic 
controls that are needed as a prerequisite to 
only “ethically” and “socially beneficial” make 
use of generally all technologies that have 




2016 | Vol. 3 | Issue 1 | IDEAS 
References 
1. Deglincerti, A. et al. Self-organization of 
the in vitro attached human embryo. 
Nature (2016). doi:10.1038/nature17948 
2. Shahbazi, M. et al. Self-organization of the 
human embryo in the absence of maternal 
tissues. Nat. Cell. Biol. (2016). 
doi:10.1038/ncb3347 
3. Wu, J. et al. An alternative pluripotent state 
confers interspecies chimaeric 
competency. Nature 21, 316–21 (2015). 
4. Hammerman, M. Classic and current 
opinion in embryonic organ transplantation. 
Curr Opin Organ Transplant. 19, 133–9 
(2014). 
5. Bedzhov, I. & Zernicka-Goetz, M. Self-
Organizing Properties of Mouse Pluripotent 
Cells Initiate Morphogenesis upon 
Implantation. Cell 156, 1032–44 (2014). 
6. Hyun, I., Wilkerson, A. & Johnston, J. 
Embryology policy: Revisit the 14-day rule. 
Nature 533, 169–171 (2016). 
7. Anton, R., Kestler, H. A. & Kühl, M. Beta-
catenin signaling contributes to stemness 
and regulates early differentiation in 
murine embryonic stem cells. FEBS Lett. 
581, 5247–5254 (2007). 
8. Glover, V. The fetus may feel pain from 20 
weeks. Conscience 25, 35–37 
9. Inoue, H., Nagata, N., Kurokawa, H. & 
Yamanaka, S. iPS cells: a game changer 
for future medicine. EMBO J 33, 409–417 
(2014). 
10. Liang, P. et al. CRISPR/Cas9-mediated 
gene editing in human tripronuclear 
zygotes. Protein Cell 6, 363–72 (2015). 
11. Callaway, E. UK scientists gain licence to 
edit genes in human embryos. Nature 530, 
(2016). 
12. Reardon, S. Gene-editing summit supports 
some research in human embryos. Nature 
(2015). doi:doi:10.1038/nature.2015.18947 
13. Ledford, H. CRISPR: gene editing is just 
the beginning. Nature 531, 156–159 
(2016). 
14. Cyranoski, D. & Reardon, S. Chinese 
scientists genetically modify human 
embryos. Nature (2015). 
doi:10.1038/nature.2015.17378 
15. Yen, S. et al. Somatic mosaicism and 
allele complexity induced by CRISPR/Cas9 
RNA injections in mouse zygotes. Dev 
Biol. 393, 3–9 (2014). 
16. James, D., Noggle, S., Swigut, T. & 
Brivanlou, A. Contribution of human 
embryonic stem cells to mouse 
blastocysts. Dev Biol. 295, 90–102 (2006). 
17. Lee, Y. et al. Establishment of a novel 
human embryonic stem cell-derived 
trophoblastic spheroid implantation model. 
Reprod. Hum. 30, 2614–26 (2015). 
18. Deglincerti, A., Etoc, F., Ozair, M. & 
Brivanlou, A. Self-Organization of Spatial 
Patterning in Human Embryonic Stem 
Cells. Curr Top Dev Biol 116, 99–113 
(2016). 
19. Reardon, S. US Congress moves to block 
human-embryo editing. Nature (2015). 
doi:10.1038/nature.2015.17858 
20. Lanphier, E., Urnov, F., Haecker, S. E., 
Werner, M. & Smolenski, J. Don’t edit the 
human germ line. Nature 519, 410–411 
(2015). 
 
